TruSignal Ear Sensor, REF TS-E-D; Oximeter
FDA Recall Z-2030-2023 · Posted 2023-07-07
Advertisement
Recalling FirmGE Healthcare Finland Oy
Recall StatusOpen, Classified
Product CodeDPZ
Date Initiated2023-05-19
Product Quantity10451 devices
Reason for Recall
There is a potential reduction of energy reaching patient during defibrillation, potential contact with unintended voltage, or inaccurate measurement.
Firm Action
GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION notice on 05/19/2023. The notice explained the safety issues associated with the us of the device and requested the actions be taken:
Actions to be taken by Customer/User for Safety Issue # 1 and #2:
1. Use an alternate method for SpO2 monitoring such as TruSignal Sensors not impacted by this field action, or an alternate SpO2 device, if possible
2. If alternate methods are not possible, the affected TruSignal SpO2 Sensors can be used for monitoring if they have not been saturated with fluids
3. If defibrillation is necessary, when the affected TruSignal SpO2 Sensors are being used, please follow the instructions below:
I. Remove the affected TruSignal SpO2 Sensor (see Table 1 below) from the patient
II. Defibrillate the patient, per hospital protocol
III. Reattach the affected TruSignal SpO2 Sensor after defibrillation is no longer needed
Actions to be taken by Customer/User for Safety Issue #3:
1. Before using Adult/Pediatric SpO2 Sensors (see Table 1), confirm that the sensor does not contain additional material covering the emitter or detector.
2. If any additional material is present, discard the sensor and select another sensor.
Root Cause
Device Design
Distribution Pattern
Worldwide
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement